Department of General and Digestive Surgery, Bariatric and Metabolic Surgery Unit, Bellvitge University Hospital, University of Barcelona, Carrer de La Feixa Llarga, S/N. 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Endocrinology, Bellvitge University Hospital, University of Barcelona, Barcelona, Spain.
Obes Surg. 2024 Jul;34(7):2293-2302. doi: 10.1007/s11695-024-07280-8. Epub 2024 May 17.
One Anastomosis Duodenal Switch (OADS/SADI-S) is used both as a one stage and a second-step procedure, either planned or revisional after a failed sleeve gastrectomy. However, there is lack of adjusted comparative evidence validating its use.
Propensity-score matched comparison between patients submitted to one-stage vs. two-step OADS, adjusted by age, gender, and initial body mass index (BMI).
One hundred ninety-five patients (130 one-stage and 65 two-step OADS) were included, with mean initial BMI 52.4 kg/m. Overall complication rate was 6.6% in the short-term (3.3% Clavien-Dindo ≥ III), and 7.3% in the long-term, with no differences between groups. Follow-up at 1 and 3 years was 83.6% and 61.5%. After one-stage OADS, total weight loss was 36.6 ± 8.2% at 1 year and 30.4 ± 10.3% at 3 years, vs. 30.2 ± 9.4% and 25.6 ± 10.2% after two-steps OADS (p = 0.021). Resolution rates of diabetes mellitus, hypertension, dyslipidemia, and obstructive sleep apnea were 86.4%, 80.4%, 78.0%, and 73.3%, with no differences between groups.
One-stage OADS is a safe and effective bariatric technique for patients with grade III and IV obesity. The two-step strategy does not reduce postoperative risks and may compromise weight loss results at mid-term.
一吻合口十二指肠转流术(OADS/SADI-S)既可以作为一期手术,也可以作为 Sleeve 胃切除术失败后的计划或修正的二步手术。然而,缺乏有效的调整后比较证据来验证其使用。
通过年龄、性别和初始体重指数(BMI)进行倾向评分匹配比较,比较接受一期和两步 OADS 的患者。
共纳入 195 例患者(130 例一期 OADS 和 65 例两步 OADS),平均初始 BMI 为 52.4kg/m²。短期(Clavien-Dindo≥III 级 3.3%)总体并发症发生率为 6.6%,长期为 7.3%,两组间无差异。1 年和 3 年的随访率分别为 83.6%和 61.5%。在一期 OADS 后,1 年时总体重减轻 36.6±8.2%,3 年时为 30.4±10.3%,而两步 OADS 后分别为 30.2±9.4%和 25.6±10.2%(p=0.021)。糖尿病、高血压、血脂异常和阻塞性睡眠呼吸暂停的缓解率分别为 86.4%、80.4%、78.0%和 73.3%,两组间无差异。
一期 OADS 是一种安全有效的治疗 III 级和 IV 级肥胖症患者的减重技术。两步策略并不能降低术后风险,并且可能会在中期影响减重效果。